This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

Japanese Encephalitis

How do you scale up a vaccine to protect more than 300 million children? We’ve worked for almost two decades with governments, manufacturers, and other partners across Asia and beyond to radically increase protection against Japanese encephalitis, a crippling and incurable disease also known as “brain fever.”

Our Work
14 Articles
14 Articles
14 Articles
  1. A girl in Nepal holds her shoulder after she has received her Japanese encephalitis vaccination 22999.jpg
    October 26, 2018

    Four barriers Nepal overcame to introduce Japanese encephalitis vaccines

    Japanese encephalitis was a formidable threat in Nepal, but it was no match for determined and creative decision-makers armed with a safe, effective, and affordable vaccine.

  2. A woman gives a girl an injection as others wait behind her.
    September 20, 2018

    How a once little-used vaccine now protects millions from Japanese encephalitis

    An incurable disease sometimes referred to as “brain fever” once ravaged communities across Asia. But thanks to PATH and our partners, Japanese encephalitis is no longer the threat it once was. A 15-year effort turned a little-known vaccine from China into an internationally approved immunization tool. The vaccine has now reached an estimated 300 million children—a turning point in the battle to protect people from this dreaded disease.

  3. Young girl in Myanmar prepares to receive the Japanese encephalitis vaccine. PATH/Thet Htoo
    July 3, 2018

    How do you protect 300 million children from deadly diseases? Partnerships are key

    On the way to vaccinating 300 million children, PATH forged partnerships from local to global levels to ensure the successful and sustainable launch of Japanese encephalitis vaccine.

  4. Two young girls holding up fingers stained with dye.
    November 22, 2017

    Myanmar launches national Japanese encephalitis vaccination campaign

    National launch builds on PATH’s long journey to bring a lifesaving vaccine to at-risk countries.

  5. 03761_hr Lab workers in the Bandung BioFarma facility in Indonesia examine vials that have vaccine vial monitor technology incorporated into their labels.
    November 6, 2017

    The vaccine vial monitor: the world's smartest sticker

  6. To ensure a vaccine is safe and effective, it must be carefully studied in the laboratory and go through several rigorous phases of clinical trials. If safety is not assured at any point, the vaccine candidate simply does not advance. Photo: PATH/Aaron Jo
    April 5, 2015

    This is how we ensure the safety of a vaccine

    At PATH, we follow a rigorous process to make safe and effective vaccines affordable and available to all families, no matter where they live.

Load more